Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Other financing activities (2024)

Catalyst Pharmaceuticals' Other financing activities history spans 1 years, with the latest figure at $296000.0 for Q1 2024.

  • For Q1 2024, Other financing activities changed N/A year-over-year to $296000.0; the TTM value through Dec 2024 reached $296000.0, changed N/A, while the annual FY2024 figure was $296000.0, N/A changed from the prior year.
  • Other financing activities reached $296000.0 in Q1 2024 per CPRX's latest filing.
  • In the past five years, Other financing activities ranged from a high of $296000.0 in Q1 2024 to a low of $296000.0 in Q1 2024.